Indrayani Biotech Limited has finalized the Basis of Allotment for its Rights Issue, approving the allocation of 83,64,036 Rights Equity Shares. These partly paid-up shares, with a face value of ₹10/- each, were issued at ₹15/- per share, including a premium of ₹5/-. The company received an application money of ₹13.75/- per share. This allotment has led to an increase in the company’s paid-up equity share capital.
Rights Issue Allotment Approved
Indrayani Biotech Limited announced today the approval of the Basis of Allotment for its Rights Issue of Rights Equity Shares. The Rights Issue Committee of the company has given the go-ahead for the allotment of 83,64,036 Rights Equity Shares. These shares are partly paid-up and have a face value of ₹10/- each. The issue price was set at ₹15/- per Rights Equity Share, which includes a premium of ₹5/- per Equity Share.
Financial Impact of Allotment
The company has received application money of ₹13.75/- per Rights Equity Share. This amount comprises ₹2.50/- towards the face value and ₹1.25/- towards the premium. The Basis of Allotment was finalized in consultation with the Designated Stock Exchange, BSE Limited, receiving their approval via email dated 02nd November 2026. Following this allotment, the paid-up equity share capital of Indrayani Biotech has seen a significant increase.
Share Capital Changes
Prior to the allotment, the company’s paid-up equity share capital stood at ₹45,53,62,560, comprising 4,55,36,256 fully paid-up equity shares of ₹10 each. Post-allotment, the paid-up equity share capital has risen to ₹53,03,95,890. This new figure includes 5,30,39,589 fully paid-up Equity Shares and 8,60,703 partly paid-up Equity Shares, with an Rs. 2.50 paid-up amount per share.
Meeting Details
The Rights Issue Committee meeting commenced at 4:30 PM and concluded at 5:30 PM on November 03, 2026.
Source: BSE
